East-West Hepatocellular Carcinoma Study Group

NCT01237132 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2010-11-09

No results posted yet for this study

Summary

The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.

Conditions

  • Carcinoma, Hepatocellular

Sponsors & Collaborators

  • University of Milan

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01237132 on ClinicalTrials.gov